16-9 NEC plans to grow healthcare and life science business to a value of 500 billion JP¥ in 2020

According to Mr Seiko Kitase, CEO of NEC, the focus of NEC’s related plans are

  1. Medical care business, e. g. analysis of image data by AI,
  2. Lifestyle support business, e. g. walking analysis of seniors (gait analysis),
  3. Life science business, such as AI-supported drug discovery

Nikkei Biotech news release, September 16, 2021

Most popular posts:

This website stores cookies on your computer. These cookies are used to provide a more personalized experience and to track your whereabouts around our website in compliance with the European General Data Protection Regulation. If you decide to to opt-out of any future tracking, a cookie will be setup in your browser to remember this choice for one year.

Accept or Deny